Splicing dysregulation as a driver of breast cancer

por Read, Abigail, Natrajan, Rachael
Publicado 2018

Definitive study shows no association between ARID1A mutation status and clinical outcome in endometriosis‐related ovarian cancers

por Khalique, Saira, Nash, Sarah, Natrajan, Rachael
Publicado 2022

Subclonal heterogeneity and evolution in breast cancer

por Mavrommati, Ioanna, Johnson, Flora, Echeverria, Gloria V., Natrajan, Rachael
Publicado 2021

An ecological measure of immune-cancer colocalization as a prognostic factor for breast cancer

por Maley, Carlo C., Koelble, Konrad, Natrajan, Rachael, Aktipis, Athena, Yuan, Yinyin
Publicado 2015

Comparative proteomic assessment of matrisome enrichment methodologies

por Krasny, Lukas, Paul, Angela, Wai, Patty, Howard, Beatrice A., Natrajan, Rachael C., Huang, Paul H.
Publicado 2016

Superior breast cancer metastasis risk stratification using an epithelial-mesenchymal-amoeboid transition gene signature

por Emad, Amin, Ray, Tania, Jensen, Tor W., Parat, Meera, Natrajan, Rachael, Sinha, Saurabh, Ray, Partha S.
Publicado 2020

An siRNA screen identifies the GNAS locus as a driver in 20q amplified breast cancer

por Garcia-Murillas, Isaac, Sharpe, Rachel, Pearson, Alex, Campbell, James, Natrajan, Rachael, Ashworth, Alan, Turner, Nicholas C
Publicado 2013

Longitudinal analysis of a secondary BRCA2 mutation using digital droplet PCR

por Khalique, Saira, Pettitt, Stephen J, Kelly, Ger, Tunariu, Nina, Natrajan, Rachael, Banerjee, Susana, Lord, Christopher J
Publicado 2019

SWATH mass spectrometry as a tool for quantitative profiling of the matrisome

por Krasny, Lukas, Bland, Philip, Kogata, Naoko, Wai, Patty, Howard, Beatrice A., Natrajan, Rachael C., Huang, Paul H.
Publicado 2018

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

por Morrison, Eamonn, Wai, Patty, Leonidou, Andri, Bland, Philip, Khalique, Saira, Farnie, Gillian, Daley, Frances, Peck, Barrie, Natrajan, Rachael
Publicado 2016

Microenvironmental Heterogeneity Parallels Breast Cancer Progression: A Histology–Genomic Integration Analysis

por Natrajan, Rachael, Sailem, Heba, Mardakheh, Faraz K., Arias Garcia, Mar, Tape, Christopher J., Dowsett, Mitch, Bakal, Chris, Yuan, Yinyin
Publicado 2016

Systematic analysis of tumour cell-extracellular matrix adhesion identifies independent prognostic factors in breast cancer

por Todd, Jason R., Ryall, Karen A., Vyse, Simon, Wong, Jocelyn P., Natrajan, Rachael C., Yuan, Yinyin, Tan, Aik-Choon, Huang, Paul H.
Publicado 2016

Assessment of the Molecular Heterogeneity of E-Cadherin Expression in Invasive Lobular Breast Cancer

por Alexander, John, Mariani, Odette, Meaudre, Celine, Fuhrmann, Laetitia, Xiao, Hui, Naidoo, Kalnisha, Gillespie, Andrea, Roxanis, Ioannis, Vincent-Salomon, Anne, Haider, Syed, Natrajan, Rachael
Publicado 2022

Microarray-Based Class Discovery for Molecular Classification of Breast Cancer: Analysis of Interobserver Agreement

por Mackay, Alan, Weigelt, Britta, Grigoriadis, Anita, Kreike, Bas, Natrajan, Rachael, A’Hern, Roger, Tan, David S.P., Dowsett, Mitch, Ashworth, Alan, Reis-Filho, Jorge S.
Publicado 2011

SF3B1 mutations constitute a novel therapeutic target in breast cancer

por Maguire, Sarah L, Leonidou, Andri, Wai, Patty, Marchiò, Caterina, Ng, Charlotte KY, Sapino, Anna, Salomon, Anne-Vincent, Reis-Filho, Jorge S, Weigelt, Britta, Natrajan, Rachael C
Publicado 2015

ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)

por Banerjee, Susana, Stewart, James, Porta, Nuria, Toms, Christy, Leary, Alexandra, Lheureux, Stephanie, Khalique, Saira, Tai, Jeremy, Attygalle, Ayoma, Vroobel, Katherine, Lord, Christopher J, Natrajan, Rachael, Bliss, Judith
Publicado 2021

Three‐dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model

por Maguire, Sarah L, Peck, Barrie, Wai, Patty T, Campbell, James, Barker, Holly, Gulati, Aditi, Daley, Frances, Vyse, Simon, Huang, Paul, Lord, Christopher J, Farnie, Gillian, Brennan, Keith, Natrajan, Rachael
Publicado 2016

The status of epidermal growth factor receptor in borderline ovarian tumours

por Showeil, Rania, Romano, Claudia, Valganon, Mikel, Lambros, Maryou, Trivedi, Pritesh, Van Noorden, Susan, Sriraksa, Ruethairat, El-Kaffash, Dalal, El-Etreby, Nour, Natrajan, Rachael, Foroni, Letizia, Osborne, Richard, El-Bahrawy, Mona
Publicado 2016

Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer

por Wilkerson, Paul M, Dedes, Konstantin J, Samartzis, Eleftherios Pierre, Dedes, Ioannis, Lambros, Maryou B, Natrajan, Rachael, Gauthier, Arnaud, Piscuoglio, Salvatore, Töpfer, Chantal, Vukovic, Vesna, Daley, Frances, Weigelt, Britta, Reis-Filho, Jorge S
Publicado 2016

Proteomics of REPLICANT perfusate detects changes in the metastatic lymph node microenvironment

por Stevenson, Julia, Barrow-McGee, Rachel, Yu, Lu, Paul, Angela, Mansfield, David, Owen, Julie, Woodman, Natalie, Natrajan, Rachael, Haider, Syed, Gillett, Cheryl, Tutt, Andrew, Pinder, Sarah E., Choudary, Jyoti, Naidoo, Kalnisha
Publicado 2021